Home >> Healthcare >> Pre Exposure Prophylaxis PrEP Market

Global Pre-Exposure Prophylaxis (PrEP) Market Size,Trends, Growth Forecast to 2031

Category : Healthcare | Report Code : 1259 | Pages : 141 | Oct 2024

Report Overview

Pre-Exposure Prophylaxis (PrEP) is a preventive medical strategy for individuals at high risk of contracting HIV, involving the use of antiretroviral medication to significantly reduce the likelihood of infection. When taken consistently, PrEP can lower the risk of HIV transmission by up to 99% in high-risk populations, such as men who have sex with men and heterosexual couples with an HIV-positive partner. PrEP typically includes medications like tenofovir disoproxil fumarate and emtricitabine, taken orally on a daily basis or as directed by a healthcare provider. The global Pre-Exposure Prophylaxis (PrEP) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the ?Pre-Exposure Prophylaxis (PrEP) Industry Forecast? looks at past sales and reviews total world Pre-Exposure Prophylaxis (PrEP) sales in 2023, providing a comprehensive analysis by region and market sector of projected Pre-Exposure Prophylaxis (PrEP) sales for 2024 through 2030. With Pre-Exposure Prophylaxis (PrEP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Exposure Prophylaxis (PrEP) industry. This Insight Report provides a comprehensive analysis of the global Pre-Exposure Prophylaxis (PrEP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Exposure Prophylaxis (PrEP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pre-Exposure Prophylaxis (PrEP) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Exposure Prophylaxis (PrEP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Exposure Prophylaxis (PrEP). United States market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Pre-Exposure Prophylaxis (PrEP) players cover Gilead Sciences, ViiV Healthcare, Teva, Amneal Pharmaceuticals, Aurobindo Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Exposure Prophylaxis (PrEP) market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Oral PrEP Injectable PrEP Segmentation by Application: Hospital and Clinic Pharmacy Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Gilead Sciences ViiV Healthcare Teva Amneal Pharmaceuticals Aurobindo Pharma Mylan Zydus Qilu Pharmaceutical Anhui Baker Biopharmaceutical Chengdu Brilliant Pharmaceutical North China Pharmaceutical Chia Tai Tianqing Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Pre-Exposure Prophylaxis (PrEP) market? What factors are driving Pre-Exposure Prophylaxis (PrEP) market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Pre-Exposure Prophylaxis (PrEP) market opportunities vary by end market size? How does Pre-Exposure Prophylaxis (PrEP) break out by Type, by Application?

Frequently Asked Questions?

Ans - The purpose of a Pre-Exposure Prophylaxis (PrEP) market research report is to provide data-driven insights and analysis on a Pre-Exposure Prophylaxis (PrEP) market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Pre-Exposure Prophylaxis (PrEP) market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.